ACAD
40.55
+0.33
+0.82%
AEMD
8.75
-0.1
-1.13%
APRI
1.56
+0.06
+4.00%
ARNA
4.19
-0.01
-0.24%
ATEC
1.36
+0.01
+0.74%
CNAT
5.36
+0.04
+0.75%
CRXM
0.5
0.00
0.00%
CYTX
0.66
-0.021
-3.0548%
DXCM
68.68
+0.43
+0.63%
GNMK
9.04
+0.01
+0.11%
HALO
17.45
+0.2
+1.16%
ILMN
205
+1.88
+0.93%
INNV
0.153
+0.003
+1.6667%
INO
8.83
+0.57
+6.90%
ISCO
0.05
0.00
0.00%
ISIS
67.76
+0.59
+0.88%
LGND
89.67
+0.44
+0.49%
LPTN
0.305
+0.008
+2.6599%
MBVX
2.29
-0.09
-3.78%
MEIP
1.87
-0.04
-2.09%
MNOV
4.05
+0.05
+1.25%
MRTX
26.81
+0.97
+3.75%
MSTX
0.49
-0.01
-2.97%
NBIX
42.55
+0.57
+1.36%
NUVA
48.25
+0.02
+0.04%
ONCS
0.233
0.00
0.00%
ONVO
4.65
-0.03
-0.64%
OREX
5.01
+0.01
+0.20%
OTIC
24.86
-6.19
-19.94%
QDEL
21.84
-0.89
-3.92%
RCPT
161.65
+1.54
+0.96%
RGLS
12.85
+0.1
+0.78%
RMD
57.08
-0.24
-0.42%
SCIE
0.02
+0.005
+30.2632%
SPHS
0.845
-0.014
-1.630%
SRNE
12.94
-0.27
-2.04%
TROV
10.93
+0.64
+6.22%
VICL
0.926
+0.036
+4.045%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
0.00
0.00%
ACAD
40.55
+0.33
+0.82%
AEMD
8.75
-0.1
-1.13%
APRI
1.56
+0.06
+4.00%
ARNA
4.19
-0.01
-0.24%
ATEC
1.36
+0.01
+0.74%
CNAT
5.36
+0.04
+0.75%
CRXM
0.5
0.00
0.00%
CYTX
0.66
-0.021
-3.0548%
DXCM
68.68
+0.43
+0.63%
GNMK
9.04
+0.01
+0.11%
HALO
17.45
+0.2
+1.16%
ILMN
205
+1.88
+0.93%
INNV
0.153
+0.003
+1.6667%
INO
8.83
+0.57
+6.90%
ISCO
0.05
0.00
0.00%
ISIS
67.76
+0.59
+0.88%
LGND
89.67
+0.44
+0.49%
LPTN
0.305
+0.008
+2.6599%
MBVX
2.29
-0.09
-3.78%
MEIP
1.87
-0.04
-2.09%
MNOV
4.05
+0.05
+1.25%
MRTX
26.81
+0.97
+3.75%
MSTX
0.49
-0.01
-2.97%
NBIX
42.55
+0.57
+1.36%
NUVA
48.25
+0.02
+0.04%
ONCS
0.233
0.00
0.00%
ONVO
4.65
-0.03
-0.64%
OREX
5.01
+0.01
+0.20%
OTIC
24.86
-6.19
-19.94%
QDEL
21.84
-0.89
-3.92%
RCPT
161.65
+1.54
+0.96%
RGLS
12.85
+0.1
+0.78%
RMD
57.08
-0.24
-0.42%
SCIE
0.02
+0.005
+30.2632%
SPHS
0.845
-0.014
-1.630%
SRNE
12.94
-0.27
-2.04%
TROV
10.93
+0.64
+6.22%
VICL
0.926
+0.036
+4.045%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
0.00
0.00%
Home » Archive by Category

Channels

How Does Biomarker Stratification Affect Drug Development Cost? It Depends. #BIO2010

May 5, 2010 – 4:43 am

On the San Diego Biotechnology Network LinkedIn group, we asked you what you wanted to hear about from the BIO Convention in Chicago, and you requested to hear about Biomarkers. Tuesday I attended a breakout …

Translational Research Forum at #BIO2010: Learning From the Land of Lincoln

May 4, 2010 – 4:26 am

I attended the translational research forum Monday morning at the BIO 2010 convention in Chicago. The morning started with Congressman Dan Lipinski from Illinois, who was a great choice as he is a member of …

#EB10 Conference Report: Lee Hood – A Systems Biology approach to prion disease

April 26, 2010 – 10:12 am

This is a post from the 2010 Experimental Biology meeting in Anaheim, part of the SDBN conference reporting channel.
Leroy Hood probably doesn’t need any introduction here, but for those who don’t know, he’s a leader …

San Diego Biotechnology Network Partner Event May 27th: Rondaxe Drug Development Symposium

April 22, 2010 – 11:59 am

Drug development is an area that, according to our 2010 poll, you are interested in, and in previous meetings we’ve discussed that San Diego biotech could grow if we would better complement our drug discovery …

#SBS10 Day 3 – Smart mice and blowing House, M.D.’s mind: Drug discovery in epigenetics

April 14, 2010 – 7:37 pm

At the afternoon session of the Society for Biomolecular Science in Phoenix, it’s all about epigenetics, the study of heritable changes that don’t involve changes in genetic sequence. Epigenetics explains why identical twins turn out a little different and why even cloned cows will have different coloration patterns.

#SBS10 report: iPS disease models coming of age for neurology

April 14, 2010 – 1:29 pm

I went to a morning session on stem cells on day 2 of the Society for Biomolecular Science meeting in Phoenix, a meeting focused on advancements in drug discovery and screening technology.  After this, it’s …

SBS Meeting report shows strong growth of Pubchem database #SBS10

April 14, 2010 – 8:46 am

At the 2010 Society for Biomolecular Science meeting on Tuesday, Steve Bryant from NIH gave a report on the increasing utility of the NIH Pubchem database for pharma drug screening programs.

SBS Day Two: A Holistic Approach To Drug Discovery #sbs10

April 14, 2010 – 7:11 am

I’m blogging from the Society for Biomolecular Sciences conference in Phoenix, the organizers were kind enough to offer two of us complimentary passes. I was surprised that the sessions were separated into disease area, technique, …

SDBN Channels: Contribute, Interact, Learn

April 13, 2010 – 7:05 am

One thing I’ve learned from starting businesses/groups, is that your grand plans don’t always happen right away, but that they are eventually realized. We started the ‘main’ SDBN group on LinkedIn in order to give …

Drug Discovery Channel–Welcome

April 11, 2010 – 3:10 pm

We are launching channels on the San Diego Biotechnology Network, where local scientists and biotechnology professionals will be able to blog and discuss the topic. Our first posts will be from the Society for Biomolecular …